Peer Review History

Original SubmissionMay 31, 2025
Decision Letter - Guadalupe Nevárez-Moorillón, Editor

Dear Dr. Yasmin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Guadalupe Virginia Nevárez-Moorillón, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: Yes

**********

Reviewer #1: The short title title is the similar to the full title.

Line 145: Please, clarify that incubation was done aerobically.

Line 158-159: It is important to state the nature and possibly the source of these isolates. Are they typed or clinical isolates.

Line 161: Please, state the measure that was taken to standardize the pathogenic inoculum before spreading it. Also state the volume that was spread on the plate.

Line 230: Recast the caption.

Reviewer #2: Current study is dealing with the prediction of probiotic potential of chicken gut associated bacteria via in-vitro analysis. Although we cannot recommend these bacteria as feed supplements without in-vivo experimentation, however, this study is forming basis for future in-vivo experimentation. So, it can be useful in future and has novelty. However, the number of assays performed for analysis of probiotic characteristics are not sufficient. Some modifications are needed to address before considering this article for publication.

Minor comments:

Methodology

1. L106: write GIT not the full term.

2. L121 and 122 are not methodology. Shift to Results section.

3. Which carbohydrates were selected for fermentation potential. Please write the names of tests.

4. Shift L120 after L114.

5. L146: Write abbreviation of colony forming units.

6. L152: Write the optical density with abbreviation and later use only abbreviation.

7. L159: Write Typhimurium as typhimurium.

8. L169-170, rephrase the sentence.

9. L201-202: rephrase and write correctly.

10. L205: remove with from with 20 each from intestine and cecum.

11. L309: Among these not of these.

12. L309, mention 4 as four.

13. L322: Mention lactic acid bacteria as LAB.

Major comments:

Methodology:

1. You did not perform serial dilution of enriched cultures. How did you get the countable number of colonies in this procedure? Kindly show the pictures of plates obtained after streaking of enriched cultures on MRS agar plates.

2. Shift molecular identification after the Morphological and biochemical characterization.

3. L164: Don’t use the term “probiotics” for these bacteria rather use fish gut born bacteria or gut associated bacteria.

4. L173-176: Describe the concentrations of antibiotics used.

5. Also perform the analysis of bacteria growth in simulated gastric medium and intestinal cell adhesion assay to confirm its probiotic characteristics. If it is easy then also perform cholesterol assimilation assay. But you should perform at least first two assays. Because number of assays documented here are not enough to confirm the probiotic potential of bacteria.

Results:

1. Figure 1 legend is not satisfactory. Describe it in detail and comprehensive way.

2. Rephrase the Table 1 caption.

3. Mention the p value in main paragraph not as foot note.

4. L243: Growth inhibition capability is not a correct term. Kindly replace with suppression.

5. L285-290: phylogenetic analysis description is very general and poor. Please discuss relation of each isolate with related genera and species with reference to bootstrap values mentioning the reliability of relation.

6. Figure 4 legend is poorly written. Kindly consult with published articles to improve your figure legends and table captions.

Discussion

1. Don’t mention human microbiota as it is irrelevant.

2. L319: bacteria did not show excellent tolerance to 6% NaCl.

3. L320: As you did not detect any stress tolerance associated protein so it is irrelevant to mention this sentence. Remove it.

4. L334: No reason to compare with pigs gut associated probiotics. There is a huge volume of literature on chicken gut probiotics. Kindly cite the relevant work.

5. Please cite more work from literature to compare the current study results.

6. In conclusion, describe one to two sentences which type of experimentation is needed in future perspectives of this study.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Fatima Muccee

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-25-29338 revised.pdf
Attachment
Submitted filename: PLOS ONE comments.docx
Revision 1

Editor-in-Chief

PLOS ONE

Dear Editor,

Re: Resubmission of Manuscript (Manuscript No: PONE-D-25-29338) Entitled, " In-vitro evaluation of probiotic potential of gut microbes isolated from retail chicken."

Thank you for the opportunity to revise and resubmit our manuscript. We appreciate the time and effort the reviewers and the editorial team have invested in evaluating our work. We have carefully considered each reviewer's comments and made the necessary revisions to address their concerns. Below, we provide a point-by-point response to each of the comments.

Additional Editor Comments:

Reviewer #1:

Comment: The short title is the similar to the full title.

Response: Short title has been changed “Isolation and characterization of chicken gut microbes for probiotic potential”.

Comment: Line 145: Please, clarify that incubation was done aerobically.

Response: Lactic acid bacteria (LAB) are facultative anaerobes capable of growing under both aerobic and anaerobic conditions. Genera such as Enterococcus, Pediococcus, and Lactococcus able to grow aerobically, and our Gram staining indicated cocci morphology. Therefore, plates were incubated aerobically in a standard incubator without sealing (no wrapping with Parafilm), allowing oxygen to diffuse freely through the Petri dish lid.

Comment: Line 158-159: It is important to state the nature and possibly the source of these isolates. Are they typed or clinical isolates.

Response: These pathogenic organisms were obtained from the Microbiology Laboratory, Department of Microbiology and Hygiene, Bangladesh Agricultural University (L168-170).

Comment: Line 161: Please, state the measure that was taken to standardize the pathogenic inoculum before spreading it. Also state the volume that was spread on the plate.

Response: Overnight grown pathogenic bacterial cultures were diluted in Buffered Peptone Water (BPW), and 200 μL (107 CFU/ml) of each bacterium was spread on Mueller-Hinton agar plates before wells were cut. LAB isolates were grown overnight in MRS broth at 370C (L170-172).

Comment: Line 230: Recast the caption.

Response: Fig 1. Tolerance of selected LAB isolates to different concentrations of NaCl. Growth of seven LAB isolates was assessed at 2%, 4%, and 6% NaCl by measuring optical density at 600 nm. The isolates exhibited strain-specific salt tolerance, with growth generally decreasing as NaCl concentration increased. Data are presented as mean ± SD (n = 3) (L245-248).

Reviewer #2:

Minor comments:

Methodology

1. Comment: L106: write GIT not the full term.

Response: GIT has been included (L108)

2. Comment: L121 and 122 are not methodology. Shift to Results section.

Response: Shifted

3. Comment: Which carbohydrates were selected for fermentation potential. Please write the names of tests.

Response: Carbohydrate fermentation (glucose, sucrose, lactose, maltose, fructose and d-mannitol) has been mentioned (L118).

4. Comment: Shift L120 after L114.

Response: Corrected (L116-119)

5. Comment: L146: Write abbreviation of colony forming units.

Response: Abbreviation of colony forming units (CFU) has been included.

6. Comment: L152: Write the optical density with abbreviation and later use only abbreviation.

Response: Optical density’s abbreviation (OD600) has been mentioned in later.

7. Comment: L159: Write Typhimurium as typhimurium.

Response: Corrected (L168)

8. Comment: L169-170, rephrase the sentence.

Response: The sentence has been rephrased (L180-181)

9. Comment: L201-202: rephrase and write correctly.

Response: Corrected (L219-220)

10. Comment: L205: remove with from with 20 each from intestine and cecum.

Response: 20 each from intestine and cecum has been removed (L223).

11. Comment: L309: Among these not of these.

Response: Corrected (L346)

12. Comment: L309, mention 4 as four.

Response: four has been mentioned (L345)

13. Comment: L322: Mention lactic acid bacteria as LAB.

Response: LAB has been mentioned (L356)

Major comments:

Methodology:

1. Comment: You did not perform serial dilution of enriched cultures. How did you get the countable number of colonies in this procedure? Kindly show the pictures of plates obtained after streaking of enriched cultures on MRS agar plates.

Response: Initially, we performed serial dilutions from pure culture and obtained the expected CFU (10⁸), which was used for further analysis. In this case, MCC6 showed the expected CFU at the 6th dilution, where 0.1 mL of culture was spread on the medium, while MCI7, MCI10, and MCC7 showed the expected CFU at the 5th dilution.

2. Comment: Shift molecular identification after the Morphological and biochemical characterization.

Response: Initially, 11 isolates were selected from a total of 40 isolates based on morphological and biochemical characterization. Subsequent screening for hemolytic activity resulted in 7 non-hemolytic isolates. Further evaluation for NaCl and simulated gastric juice tolerance reduced the number to 4 isolates. Finally, bile salt tolerance, antimicrobial activity, and antibiotic sensitivity tests confirmed the selection of these same 4 isolates. Therefore, proceeding with molecular identification immediately after morphological and biochemical characterization would not be logical.

3. Comment: L164: Don’t use the term “probiotics” for these bacteria rather use fish gut born bacteria or gut associated bacteria.

Response: Gut associated bacteria has been included (L175)

4. Comment: L173-176: Describe the concentrations of antibiotics used.

Response: The concentrations of antibiotics have been mentioned in bracket (L184-187)

5. Comment: Also perform the analysis of bacteria growth in simulated gastric medium and intestinal cell adhesion assay to confirm its probiotic characteristics. If it is easy then also perform cholesterol assimilation assay. But you should perform at least first two assays. Because number of assays documented here are not enough to confirm the probiotic potential of bacteria.

Response: Simulated gastric medium (L148-156) and intestinal cell adhesion assay (L191-197) have been performed.

Results:

1. Comment: Figure 1 legend is not satisfactory. Describe it in detail and comprehensive way.

Response: We have revised the Figure 1 legend to provide a clearer and more comprehensive description (L 245-248)

2. Comment: Rephrase the Table 1 caption.

Response: We have revised the Table 1 legend to provide a clearer and more comprehensive description (L 120-121)

3. Comment: Mention the p value in main paragraph not as foot note.

Response: p value has been mentioned in main paragraph.

4. Comment: L243: Growth inhibition capability is not a correct term. Kindly replace with suppression.

Response: Suppression has been replaced with growth inhibition capability (L271).

5. Comment: L285-290: phylogenetic analysis description is very general and poor. Please discuss relation of each isolate with related genera and species with reference to bootstrap values mentioning the reliability of relation.

Response: We have revised the phylogenetic analysis and discussed relation of each isolate with related genera and species with reference to bootstrap values mentioning the reliability of relation (L320-326).

6. Comment: Figure 4 legend is poorly written. Kindly consult with published articles to improve your figure legends and table captions.

Response: Figure 4 replaced with Figure 6 and revised the figure legend to provide a clearer and more comprehensive description (L327-330).

Discussion

1. Comment: Don’t mention human microbiota as it is irrelevant.

Response: Citation and reference of human microbiota has been removed.

2. Comment: L319: bacteria did not show excellent tolerance to 6% NaCl.

Response: Corrected (L 356)

3. Comment: L320: As you did not detect any stress tolerance associated protein so it is irrelevant to mention this sentence. Remove it.

Response: The line has been removed.

4. Comment: L334: No reason to compare with pigs gut associated probiotics. There is a huge volume of literature on chicken gut probiotics. Kindly cite the relevant work.

Response: Pigs gut associated probiotics have been removed and included chicken gut probiotics associated literature.

5. Comment: Please cite more work from literature to compare the current study results.

Response: Current literature has been included

6. Comment: In conclusion, describe one to two sentences which type of experimentation is needed in future perspectives of this study.

Response: The future perspectives have been included in the conclusion section of discussion (L421-425).

Additional comments:

Q: 142 line- Why and how could plates for the growth of LAB be incubated aerobically?

Response: Lactic acid bacteria (LAB) are facultative anaerobes capable of growing under both aerobic and anaerobic conditions. Genera such as Enterococcus, Pediococcus, and Lactococcus able to grow aerobically, and our Gram staining indicated cocci morphology. Therefore, plates were incubated aerobically in a standard incubator without sealing (no wrapping with Parafilm), allowing oxygen to diffuse freely through the Petri dish lid.

Q: 160 line- What same condition? Do you mean MRS broth was used to grow pathogens because BPW is not a culture medium.

Response: Overnight grown pathogenic bacterial cultures were diluted in Buffered Peptone Water (BPW), and 200 μL (107 CFU/ml) of each bacterium was spread on Mueller-Hinton agar plates before wells were cut. LAB isolates were grown overnight in MRS broth at 370 C (L170-172).

We hope that current revisions are sufficient to make our manuscript suitable for publication in the PLOS ONE Journal and look forward to hearing from you at your earliest convenience.

Sincerely,

Sabina Yasmin

Professor

Institute of Biotechnology

Bangladesh Agricultural University

Mymensingh-2202, Bangladesh

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Guadalupe Nevárez-Moorillón, Editor

In-vitro evaluation of probiotic potential of gut microbes isolated from retail chicken.

PONE-D-25-29338R1

Dear Dr. Yasmin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Guadalupe Virginia Nevárez-Moorillón, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Guadalupe Nevárez-Moorillón, Editor

PONE-D-25-29338R1

PLOS One

Dear Dr. Yasmin,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Guadalupe Virginia Nevárez-Moorillón

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .